Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

How I treat secondary acute myeloid leukemia

Steven D. Green, Eunice S. Wang

Blood (2025) 145 (12): 1260–1272.

https://doi.org/10.1182/blood.2024024011

Published: 2025

Journal Articles

Gemtuzumab Ozogamicin Plus Standard Induction Chemotherapy Improves Outcomes in Intermediate Risk Cytogenetic Acute Myeloid Leukemia

Hassan Awada, Mina Abdelmalek, Tara L. Cronin, Jeffrey Baron, Zakariya Kashour, Farhan Azad, Muhammad Salman Faisal, Mark G. Faber, Arya Roy, Ashish Gupta, Matthew Gravina, Sheeba Ba Aqeel, Alankrita Taneja, Pamela J. Sung, Steven D. Green, Amanda Przespolewski, James E. Thompson, Elizabeth A. Griffiths, Eunice S. Wang

Blood (2022) 140 (Supplement 1): 135–136.

https://doi.org/10.1182/blood-2022-168482

Published: 2022

Journal Articles

MRD Status and ELN 2022 Predicts for Outcomes of Venetoclax + Hypomethylating Therapy in AML: Single-Center Real-World Analysis

Mark G. Faber, Jeffrey Baron, Han Yu, Hassan Awada, Tara L. Cronin, James E. Thompson, Amanda Przespolewski, Steven D. Green, Pamela J. Sung, Elizabeth A. Griffiths, Eunice S. Wang

Blood (2022) 140 (Supplement 1): 9010–9012.

https://doi.org/10.1182/blood-2022-164707

Published: 2022

Journal Articles

Preliminary Data from the Phase I/II Study of TP-3654, a Selective Oral PIM1 Kinase Inhibitor, in Patients with Myelofibrosis Previously Treated with or Ineligible for JAK Inhibitor Therapy

Firas El Chaer, James McCloskey, Lindsay A.M. Rein, Randy A. Brown, Steven D. Green, Jeffrey J. Pu, Shuichi Shirane, Kazuya Shimoda, Michiko Ichii, Junichiro Yuda, Joseph Scandura, Sujan Kabir, Jason M Foulks, Jian Mei, Huyuan Yang, Mark Wade, Carl Stapinski, Claudia Lebedinsky, Raajit K Rampal

Blood (2022) 140 (Supplement 1): 594–595.

https://doi.org/10.1182/blood-2022-159086

Published: 2022

Journal Articles

Phase II Study of Tagraxofusp in Newly Diagnosed Secondary Acute Myeloid Leukemia (S-AML) after Previous Exposure to Hypomethylating Agents (TAGALONG Study)

Steven D. Green, Brian Parkin, Catherine Lai, Ivana Gojo, Matthew C. Foster, Joshua F. Zeidner

Blood (2022) 140 (Supplement 1): 11749–11750.

https://doi.org/10.1182/blood-2022-170738

Published: 2022

Journal Articles

L-Glutamine Increases IGF-1 Liver Expression to Prevent Bone Loss in Sickle Mice

Mykel D Green, Mitchell Schaffler, PhD, Gilda A Barabino, PhD

Blood (2019) 134 (Supplement_1): 3561.

https://doi.org/10.1182/blood-2019-128950

Published: 2019

Journal Articles

Retrospective Outcomes of Prolonged-Duration Calcineurin Inhibitor Immunosuppression in Severe Aplastic Anemia

Steven D. Green, MD, Joyatee M. Sarker, PhD, Erica B. Bernhardt, MD, Muhammad Khawaja, MBBS,MPH, Robert P. Nelson, Jr., MD

Blood (2017) 130 (Supplement 1): 1186.

https://doi.org/10.1182/blood.V130.Suppl_1.1186.1186

Published: 2017

Journal Articles

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription

Blood (2013) 122 (5): 738–748.

https://doi.org/10.1182/blood-2012-08-447441

Published: 2013

Includes: Supplemental data

Journal Articles

Genomics in 2K10: Fulfilling the Promise of a Sequenced Human Genome

Eric D. Green, MD, PhD

Blood (2010) 116 (21): SCI-16.

https://doi.org/10.1182/blood.V116.21.SCI-16.SCI-16

Published: 2010

Journal Articles

Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation

Anissa M. Jabbour, Carmel P. Daunt, Benjamin D. Green, Sandra Vogel, Lavinia Gordon, Rachel S. Lee, Natasha Silke, Richard B. Pearson, Cassandra J. Vandenberg, Priscilla N. Kelly, Stephen L. Nutt, Andreas Strasser, Christoph Borner, Paul G. Ekert

Blood (2010) 115 (2): 344–352.

https://doi.org/10.1182/blood-2009-07-230730

Published: 2010

Includes: Supplemental data

Journal Articles

Regulated Hox Gene Expression Reveals a Novel Role for Hox Genes in Myeloid Cell Proliferation and Survival

Marika Salmanidis, Gabi Brumatti, Anissa M Jabbour, Benjamin D Green, John Silke, Philippe Bouillet, Paul G Ekert, MB.BS, PhD, FRACP

Blood (2008) 112 (11): 5323.

https://doi.org/10.1182/blood.V112.11.5323.5323

Published: 2008

Journal Articles

Identification of PML-RARa Target Genes Using Microarray and ChIP-on-Chip Analysis.

Wenlin Yuan, PhD, Nicole R. Grieselhuber, BS, Roland D. Green, Timothy J. Ley, MD

Blood (2005) 106 (11): 2994.

https://doi.org/10.1182/blood.V106.11.2994.2994

Published: 2005

Journal Articles

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34

Robert W. Storms, Patrick D. Green, Kristine M. Safford, Donna Niedzwiecki, Christopher R. Cogle, O. Michael Colvin, Nelson J. Chao, Henry E. Rice, Clayton A. Smith

Blood (2005) 106 (1): 95–102.

https://doi.org/10.1182/blood-2004-09-3652

Published: 2005

Journal Articles

Gene Conversion of Sialic Acid Binding Domains in CD33-Related Siglecs by Adjacent Pseudogenes: A Novel Mechanism To Change Sialic Acid Binding Specificity.

Toshiyuki Hayakawa, Takashi Angata, Elliott H. Margulies, Tarjei Mikkelsen, Eric D. Green, Ajit Varki

Blood (2004) 104 (11): 1471.

https://doi.org/10.1182/blood.V104.11.1471.1471

Published: 2004

Journal Articles

Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor

Christian P. Kratz, Brooke M. Emerling, Jeannette Bonifas, Winfred Wang, Eric D. Green, Michelle M. Le Beau, Kevin M. Shannon

Blood (2002) 99 (1): 372–374.

https://doi.org/10.1182/blood.V99.1.372

Published: 2002

Journal Articles

Randomized, Blinded, Placebo-Controlled Phase I Trial of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor With Filgrastim After Dose-Intensive Chemotherapy in Patients With Advanced Cancer

Russell L. Basser, John E.J. Rasko, Kerrie Clarke, Jonathan Cebon, Michael D. Green, Andrew P. Grigg, John Zalcberg, Brian Cohen, Joan O'Byrne, Dora M. Menchaca, Richard M. Fox, C. Glenn Begley

Blood (1997) 89 (9): 3118–3128.

https://doi.org/10.1182/blood.V89.9.3118

Published: 1997

Journal Articles

A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin

RS Schwartz, DA Gabriel, LM Aledort, D Green, CM Kessler

Blood (1995) 86 (2): 797–804.

https://doi.org/10.1182/blood.V86.2.797.bloodjournal862797

Published: 1995

Journal Articles

Effect of fish oil on platelet adhesiveness [letter; comment]

D Green

Blood (1991) 77 (1): 207–208.

https://doi.org/10.1182/blood.V77.1.207.207

Published: 1991

Journal Articles

Hematin: unique effects of hemostasis

R Glueck, D Green, I Cohen, CH Ts'ao

Blood (1983) 61 (2): 243–249.

https://doi.org/10.1182/blood.V61.2.243.243

Published: 1983

Journal Articles

Lower factor VIII coagulant in daughters of subjects with hemophilia A compared to other obligate carriers

J Chediak, MC Telfer, T Jaojaroenkul, D Green

Blood (1980) 55 (4): 552–558.

https://doi.org/10.1182/blood.V55.4.552.552

Published: 1980

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

How I treat secondary acute myeloid leukemia

Gemtuzumab Ozogamicin Plus Standard Induction Chemotherapy Improves Outcomes in Intermediate Risk Cytogenetic Acute Myeloid Leukemia

MRD Status and ELN 2022 Predicts for Outcomes of Venetoclax + Hypomethylating Therapy in AML: Single-Center Real-World Analysis

Preliminary Data from the Phase I/II Study of TP-3654, a Selective Oral PIM1 Kinase Inhibitor, in Patients with Myelofibrosis Previously Treated with or Ineligible for JAK Inhibitor Therapy

Phase II Study of Tagraxofusp in Newly Diagnosed Secondary Acute Myeloid Leukemia (S-AML) after Previous Exposure to Hypomethylating Agents (TAGALONG Study)

L-Glutamine Increases IGF-1 Liver Expression to Prevent Bone Loss in Sickle Mice

Retrospective Outcomes of Prolonged-Duration Calcineurin Inhibitor Immunosuppression in Severe Aplastic Anemia

Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription

Genomics in 2K10: Fulfilling the Promise of a Sequenced Human Genome

Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation

Regulated Hox Gene Expression Reveals a Novel Role for Hox Genes in Myeloid Cell Proliferation and Survival

Identification of PML-RARa Target Genes Using Microarray and ChIP-on-Chip Analysis.

Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34

Gene Conversion of Sialic Acid Binding Domains in CD33-Related Siglecs by Adjacent Pseudogenes: A Novel Mechanism To Change Sialic Acid Binding Specificity.

Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor

Randomized, Blinded, Placebo-Controlled Phase I Trial of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor With Filgrastim After Dose-Intensive Chemotherapy in Patients With Advanced Cancer

A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin

Effect of fish oil on platelet adhesiveness [letter; comment]

Hematin: unique effects of hemostasis

Lower factor VIII coagulant in daughters of subjects with hemophilia A compared to other obligate carriers

Email alerts

ASH Publications

American Society of Hematology